Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — Investor Presentation (October 2024)
7 slides from Curvebeam Ai's investor presentation, Oct 31, 2024
Slide 1: Quarterly 4C Conference Call
QUARTERLY 4C CONFERENCE CALL 31 October 2024
Slide 2: Disclaimer
DISCLAIMER Introduction THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, Forward looking statements DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA OR TO ANY The information given in this presentation is given for illustrative purposes only
Slide 3: 4C Summary of Key Activities
4C SUMMARY OF KEY ACTIVITIES • CurveBeam AI received purchase orders (POs) for three (3) devices in Q1 FY25, level with the prior corresponding period of three (3) devices in Q1 FY24. • The Company announced FDA clearance for the enhanced HiRise™ in Q1 FY25. • Capital raising (ANREO & Placement) com
Slide 4: Cashflows from Operations & Runway
Cashflows from Operations & Runway • Capital raising (ANREO & Placement) completed in Q1 FY25 of A$11.54m. • The cash on hand at the end of Q1 was A$10.1m, equating to 2.13 quarters of cash at the level of net cash outflow from operations for Q1 FY25 quarter. • Note this cash figure does not include
Slide 5: Enhanced HiRise Project for Robotic Surgical Systems
ENHANCED HIRISE™ PROJECT FOR ROBOTIC SURGICAL SYSTEMS • CurveBeam AI has completed the development of the Enhanced HiRise™ platform and is now FDA 510(k) cleared. CE and TGA targeted next. • Enhanced HiRise™ WBCT scans, with higher energy X-Ray source, allows key anatomical landmarks to be identifie
Slide 6: In Closing
IN CLOSING • Enhanced HiRise™ progress • Enhanced HiRise™ FDA clearance was achieved in July 2024. • Key validation steps for a robotic surgical system at two US based sites with the enhanced HiRise™ were completed. • Both sites have imaged patients on the enhanced HiRise™ with positive feedback rec
Slide 7: Definitions
DEFINITIONS CurveBeam AI’s key metrics are defined and interpreted as follows: • Purchase order – a signed purchase order (PO) for a CT scanner (device). The Company considers POs to be a key metric as it reflects actual sales at any given time. • Receipts from customers – any cash consideration rec